April 3, 2024 · Form 4 insider transaction
Bohnen Shane bought 2,259 shares of Bio-Techne Corporation, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.